Paroxetine Tablet, Film Coated
Product Images NDC 55289-053

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 55289-053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

55289053 Labels (55289053)

Paroxetine USP 40 mg film-coated tablets packaging label showing a quantity of 90 tablets. The label includes the NDC 55289-053-90, lot number G20A23, and expiration date 03/2022. It is labeled by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. Warnings on the label advise keeping the medication out of reach of children and not consuming alcohol while taking this medication.*

FDA Label Image

Image 01

Chemical structure diagram of paroxetine hydrochloride hemihydrate showing its molecular components including a fluorophenyl group, a piperidine ring, a dioxolane ring, and the hydrochloride with half a water molecule hydrate.*

FDA Label Image

Image 06

A scatter plot showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of five interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, Phenytoin 300 mg) relative to reference values. The x-axis is labeled 'Change relative to reference' on a logarithmic scale ranging from 0.1 to 10.0.*

FDA Label Image

Image 07

A pharmacokinetic plot showing fold change and 90% confidence intervals for Cmax and AUC of paroxetine when co-administered with various interacting drugs (cimetidine, phenobarbital, phenytoin, digoxin, and diazepam). The horizontal axis represents change relative to reference from 0 to 2, with data points and error bars illustrating the effects of each interacting drug on these PK parameters.*

FDA Label Image

Image 08

A forest plot showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, Cmin) of Paroxetine in different populations and conditions, including mild to severe renal impairment, hepatic impairment, age groups over 65 years at various doses, and gender (males). The x-axis represents change relative to reference on a logarithmic scale from 0.5 to 50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.